# PROGRESSIVE CORP/OH/ (PGR) · Edgar & Edgarette company card

> Progressive (PGR) grew revenue 16.3% in FY2025 to $87.7 billion, equity 24.6% of assets, and dividend per share up 3 years running. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 80661 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/PGR) · [JSON](https://www.pops4.com/boards/company/PGR.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $87.7B |
| Revenue growth, 1 year | 16.3% |
| Revenue growth per year | 16.4% |
| Operating margin | — |
| Net margin | 12.9% |
| Operating cash flow | $17.5B |
| Capital spending | $348M |
| Free cash flow | $17.2B |
| Cash | $138M |
| Long-term debt | $6.9B |
| Total assets | $123.0B |
| Total equity | $30.3B |
| Equity ÷ assets | 24.6% |
| Return on equity | 37.3% |
| Dividend per share | $13.9 |
| Dividend years rising | 3 |

## Readings, computed from those figures

- Piotroski F: 6 of 9 (solid)
- Health Harbor boat: New ship · no warning signs
- Cash Compass: Cash cow later · growing fast, and already turning revenue into cash

## Edgarette's reading

Exposure: revenue $87.7B (FY2025), total debt $6.9B. Experience: revenue up 16.3% on the year, up 16.4% a year over 4 years. Soundness: equity 24.6% of assets, return on equity 37.3%, payout 25.4% of profit, dividend per share up 3 years running. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $90.8B and $111.1B next year (method v4.1: its own 4-year record of growth weighed at 50% against $10B+ filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $83.1B to $120.5B. A statistical range, not company guidance. Against peers (54 filers, $50M+ revenue, fire, marine & casualty insurance): growth 16.3% against 7.4%.

Range logged 2026-09-26, receipt adb3671d6c27efca, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 3, latest 2026-06-17 ([filing](https://www.sec.gov/Archives/edgar/data/80661/000008066126000210/0000080661-26-000210-index.htm))

## Recent filings

- 10-Q · filed 2026-11-02 · [filing](https://www.sec.gov/Archives/edgar/data/80661/000008066126000379/0000080661-26-000379-index.htm)
- 8-K · filed 2026-10-14 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/80661/000008066126000367/0000080661-26-000367-index.htm)
- 8-K · filed 2026-09-18 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/80661/000008066126000322/0000080661-26-000322-index.htm)
- 8-K · filed 2026-08-19 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/80661/000008066126000315/0000080661-26-000315-index.htm)
- 8-K · filed 2026-08-10 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/80661/000008066126000310/0000080661-26-000310-index.htm)
- 10-Q · filed 2026-08-03 · [filing](https://www.sec.gov/Archives/edgar/data/80661/000008066126000308/0000080661-26-000308-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0000080661.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=80661

## Cite

POPS4, Edgar & Edgarette: PROGRESSIVE CORP/OH/ (PGR) company card, from the company's own SEC filings, accessed 2026-11-10, https://www.pops4.com/boards/company/PGR. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.